Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial Infarction: Title and subTitle BreakTIMI II A Results FREE

[+] Author Affiliations

Reprint requests to TIMI Coordinating Center, Maryland Medical Research Institute Inc, 600 Wyndhurst Ave, Baltimore, MD 21210 (Genell Knatterud, PhD).

JAMA. 1988;260(19):2849-2858. doi:10.1001/jama.1988.03410190097031

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

The Thrombolysis in Myocardial Infarction II A Study investigated whether immediate cardiac catheterization with percutaneous transluminal coronary angioplasty (PTCA), when appropriate, would confer an advantage over the same procedures performed 18 to 48 hours later. All patients were treated with intravenous recombinant tissue—type plasminogen activator within four hours of the onset of acute myocardial infarction. Percutaneous transluminal coronary angioplasty of the infarct-related artery was attempted in 72% of the 195 patients assigned to immediate PTCA; 84% of the attempts were judged to have shown improvement. Percutaneous transluminal coronary angioplasty was attempted in 55% of the 194 patients assigned to 18- to 48-hour PTCA; 93% of the attempts were judged to have shown improvement. No differences between the two PTCA groups were observed for ejection fraction (primary end point), measured by contrast ventriculography predischarge (50.3% in the immediate and 49.0% in the delayed PTCA groups). Immediate catheterization/angioplasty was associated with increased frequency of bleeding and coronary artery bypass surgery. These findings indicate that immediate performance of coronary arteriography and PTCA compared with delaying these procedures for 18 to 48 hours provides no advantage and may be harmful.

(JAMA 1988;260:2849-2858)

REFERENCES

ABSTRACT | REFERENCES

Monthly Vital Statistics Report . National Center for Health Statistics, 1987;, vol 35.

1986 Summary: National Hospital Discharge Survey . National Center for Health Statistics, 1987;.

DeWood MA, Spores J, Notske R, et al: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction . N Engl J Med 1980;;303:897-902.

Rentrop PK: Thrombolytic therapy in patients with acute myocardial infarction . Circulation 1985;;71:627-631.

Simoons ML, van der Brand M, de Zwabb C, et al: Improved survival after early thrombolysis in acute myocardial infarction . Lancet 1985;;2:578-581.

GISSI: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction . Lancet 1986;;1:397-402.

AIMS Trial Study Group: Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial . Lancet 1988;;1:546-549.

Chesebro JH, Knatterud GL, Roberts R, et al: Thrombolysis in Myocardial Infarction (TIMI) Trial Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase—clinical findings through hospital discharge . Circulation 1987;;76:142-154.

Williams DO, Borer J, Braunwald E, et al: Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: A report from the NHLBI Thrombolysis in Myocardial Infarction Trial . Circulation 1986;; 73:338-346.

Passamani E, HodgesM, Herman M, et al: The Thrombolysis in Myocardial Infarction (TIMI) Phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty . J Am Coll Cardiol 1987;;10:51B-64B.

TIMI Operations Committee, Braunwald E, Knatterud GL, et al: Announcement of protocol change in Thrombolysis in Myocardial Infarction Trial . J Am Coll Cardiol 1987;;9:467.

TIMI Operations Committee, Braunwald E, Knatterud GL, et al: Update from the Thrombolysis in Myocardial Infarction (TIMI) Trial . J Am Coll Cardiol 1987;;10:970.

Brown BG, Bolson EL, Frimer M, et al: Quantitative coronary arteriography: Estimation of dimensions, hemodynamic resistance and atheroma mass of coronary artery lesions using the arteriogram and digital computation . Circulation 1977;;55:329.

Snedecor GW, Cochran WG: Statistical Methods . Ames, The Iowa State University Press, 1967;, pp 100-106,128-130.

Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observations in each patient: I. Introduction and design . Br J Cancer 1976;;34:585-612.

Topol EJ, Califf RM, George BS, et al: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction . N Engl J Med 1987;;317:581-588.

Bovill E: Dose response relationship of rt-PA infusion to induction of systemic fibrin(ogen)olysis in the Thrombolysis in Myocardial Infarction (TIMI) Trial . Blood 1987;;70( (suppl 1) ):367a.

Simoons ML, Betriu A, Col J, et al: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate coronary angioplasty . Lancet 1988;;1:197-203.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal